<DOC>
	<DOCNO>NCT00099242</DOCNO>
	<brief_summary>The goal research study evaluate safety efficacy rivastigmine transdermal patch patient probable Alzheimer 's Disease .</brief_summary>
	<brief_title>Efficacy Safety Rivastigmine Transdermal Patch Patients With Probable Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<criteria>Diagnosis dementia Alzheimer 's type Males , females surgically sterile one year postmenopausal A primary caregiver willing accept responsibility supervise treatment Any condition ( Alzheimer 's ) could explain patient 's dementia An advanced , severe unstable disease may put patient special risk Current diagnosis active , uncontrolled seizure disorder unstable cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Dementia</keyword>
</DOC>